These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30428683)

  • 21. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias.
    Chowdhury M; Wong J; Cheng A; Khilkin M; Palma E
    Cardiovasc Ther; 2015 Jun; 33(3):127-33. PubMed ID: 25825202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
    Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
    Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
    Kao DP; Haigney MC; Mehler PS; Krantz MJ
    Addiction; 2015 Sep; 110(9):1468-75. PubMed ID: 26075588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsades de pointes with methadone.
    Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.
    van den Beuken-van Everdingen MH; Geurts JW; Patijn J
    J Opioid Manag; 2013; 9(4):263-7. PubMed ID: 24353019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone prolongs cardiac conduction in young patients with cancer-related pain.
    Anghelescu DL; Patel RM; Mahoney DP; Trujillo L; Faughnan LG; Steen BD; Baker JN; Pei D
    J Opioid Manag; 2016; 12(2):131-8. PubMed ID: 27194198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective Cohort.
    Bart G; Wyman Z; Wang Q; Hodges JS; Karim R; Bart BA
    J Addict Med; 2017; 11(6):489-493. PubMed ID: 28863009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
    Vallecillo G; Mojal S; Roquer A; Martinez D; Rossi P; Fonseca F; Muga R; Torrens M
    Clin Infect Dis; 2013 Oct; 57(8):1189-94. PubMed ID: 23899678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose methadone and QTc prolongation: strategies to optimize safety.
    Schmittner J; Krantz MJ
    J Opioid Manag; 2006; 2(1):49-55. PubMed ID: 17319118
    [No Abstract]   [Full Text] [Related]  

  • 34. QTc interval prolongation associated with intravenous methadone.
    Kornick CA; Kilborn MJ; Santiago-Palma J; Schulman G; Thaler HT; Keefe DL; Katchman AN; Pezzullo JC; Ebert SN; Woosley RL; Payne R; Manfredi PL
    Pain; 2003 Oct; 105(3):499-506. PubMed ID: 14527710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The successful use of parenteral methadone in a patient with a prolonged QTc interval.
    Sekine R; Obbens EA; Coyle N; Inturrisi CE
    J Pain Symptom Manage; 2007 Nov; 34(5):566-9. PubMed ID: 17616330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone for pain and the risk of adverse cardiac outcomes.
    Price LC; Wobeter B; Delate T; Kurz D; Shanahan R
    J Pain Symptom Manage; 2014 Sep; 48(3):333-42.e1. PubMed ID: 24480532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluctuating QTc interval in an asymptomatic patient treated with methadone for chronic pain.
    Ower K; Morley-Forster P; Moulin D
    J Opioid Manag; 2005; 1(2):73-6. PubMed ID: 17319250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.
    Fareed A; Vayalapalli S; Scheinberg K; Gale R; Casarella J; Drexler K
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):235-40. PubMed ID: 23808912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onsite QTc interval screening for patients in methadone maintenance treatment.
    Fareed A; Vayalapalli S; Byrd-Sellers J; Casarella J; Drexler K; Amar R; Smith-Cox J; Lutchman TS
    J Addict Dis; 2010 Jan; 29(1):15-22. PubMed ID: 20390695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.